Skip to content

Glossary

Three colleagues wearing masks and standing in front of a wall full of sticky notes look at a tablet device
Home
Reporting Hub
Glossary

Glossary

Acronym Definition placeholder placeholder
AI Artificial intelligence
placeholder
placeholder
AIDS Acquired immunodeficiency syndrome
placeholder
placeholder
AMR Antimicrobial resistance
placeholder
placeholder
ARV Antiretroviral
placeholder
placeholder
BARDA Biomedical Advanced Research and Development Authority, part of the U.S. Department of Health and Human Services
placeholder
placeholder
CDC Centers for Disease Control and Prevention
placeholder
placeholder
DEI Diversity, equity and inclusion
placeholder
placeholder
DR-TB Drug-resistant tuberculosis
placeholder
placeholder
ECDC European Centre for Disease Prevention and Control
placeholder
placeholder
EH&S Environmental Health & Safety
placeholder
placeholder
EMA European Medicines Agency
placeholder
placeholder
EMEA Europe, Middle East and Africa
placeholder
placeholder
EML WHO Model List of Essential Medicines
placeholder
placeholder
ESG Environmental, social and governance
placeholder
placeholder
EUA Emergency Use Authorization
placeholder
placeholder
EUL Emergency Use Listing

placeholder
placeholder
ExPEC Extraintestinal pathogenic Escherichia coli
placeholder
placeholder
FDA U.S. Food and Drug Administration
placeholder
placeholder
GCI Global Community Impact
placeholder
placeholder
GBP Global Brand Protection
placeholder
placeholder
GHG Greenhouse gas or gases
placeholder
placeholder
GPH Global Public Health
placeholder
placeholder
HCP Healthcare professional
placeholder
placeholder
HIV Human immunodeficiency virus
placeholder
placeholder
IP Intellectual Property
placeholder
placeholder
JJBC Johnson & Johnson Bioethics Committee
placeholder
placeholder
JJDC Johnson & Johnson Innovation—JJDC, Inc.
placeholder
placeholder
J&J MedTech Johnson & Johnson MedTech
placeholder
placeholder
JLABS Johnson & Johnson Innovation—JLABS
placeholder
placeholder
LAI Long-acting injectable
placeholder
placeholder
LMICs Low- and middle-income countries
placeholder
placeholder
MDR-TB Multidrug-resistant tuberculosis
placeholder
placeholder
NGO Non-governmental organization
placeholder
placeholder
NIH National Institutes of Health
placeholder
placeholder
OCMO The Johnson & Johnson Office of the Chief Medical Officer
placeholder
placeholder
PAH Pulmonary arterial hypertension
placeholder
placeholder
PPE Personal protective equipment
placeholder
placeholder
PTA Priority Topics Assessment
placeholder
placeholder
RLS Resource-limited settings
placeholder
placeholder
RNA Ribonucleic acid
placeholder
placeholder
RSV Respiratory syncytial virus
placeholder
placeholder
RWD Real-world data
placeholder
placeholder
SDG Sustainable Development Goal (of the United Nations)
placeholder
placeholder
SEC U.S. Securities and Exchange Commission
placeholder
placeholder
SSP Supplier Sustainability Program
placeholder
placeholder
STEM Science, Technology, Engineering, and Mathematics
placeholder
placeholder
STH Soil-transmitted helminthiasis (or intestinal parasites)
placeholder
placeholder
TB Tuberculosis
placeholder
placeholder
VR Virtual reality
placeholder
placeholder
WHO World Health Organization
placeholder
placeholder
Previous Report Builder Next References
Back to Top